Novartis in Society Integrated Report 2022

Strengthen our foundations

2022 highlights

47%

Women in management
compared with 46% in 2021

250 m

Pledged (USD)
for research into new medicines for malaria and neglected tropical diseases

54.6 m

Patients reached
through access-to-medicine approaches

98%

Employees trained
on our Code of Ethics

In this section

Unleash the power of our people We continue to focus on culture as a key enabler of our strategy to drive innovation and long-term performance. Scale data science and technology We are investing in data science and technology to improve the way we develop and deliver our medicines. Build trust with society We aim to increase access to our medicines for underserved populations around the world and follow high standards of ethical behavior wherever we operate.

Topic filter

Results